All-trans retinoic acid induces p62DOK1 and p56DOK2 expression which enhances induced differentiation and G0 arrest of HL-60 leukemia cells

American Journal of Hematology

Volumn 81, Issue 8, 2006, Pages 603-615

  Lamkin, Thomas J ^a   Chin, Vivian ^a   Yen, Andrew ^a  

^a Cornell University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CALCITRIOL; DOCKING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN DOK1; PROTEIN DOK2; PROTEIN P56; PROTEIN P62; PROTEIN TYROSINE KINASE; RETINOIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE ARREST; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRAIN HL 60; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FIBROBLAST; HUMAN; HUMAN CELL; LEUKEMIA CELL; LEUKEMOGENESIS; MYELOID LEUKEMIA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE HOMOLOGY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CALCITRIOL; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; DNA-BINDING PROTEINS; DRUG SCREENING ASSAYS, ANTITUMOR; FLOW CYTOMETRY; G0 PHASE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, LEUKEMIC; HL-60 CELLS; HUMANS; LEUKEMIA, MYELOMONOCYTIC, ACUTE; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MOLECULAR SEQUENCE DATA; PHENOTYPE; PHOSPHOPROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; TIME FACTORS; TRETINOIN;

EID: 33746020803     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20667     Document Type: Article

References (66)

1. Yamanashi Y. Tamura T, Kanamori T, Yamane H, Nariuchi H, Yamamoto T, Baltimore D. Role of the rasGAP-associated docking protein p62 (dok) in negative regulation of B cell receptor-mediated signaling. Genes Dev 2000;14:11-16.
2. Tamir I, Stolpa JC, Helgason CD, Nakamura K, Bruhns P, Daeron M, Gambier JC. The RasGAP-binding protein p62dok is a mediator of inhibitory FcgammaRIIB signals in B cells. Immunity 2000;12:347-358.
3. Suzu S, Tanaka-Douzono M, Nomaguchi K, Yamada M, Hayasawa H, Kimura F. Motoyoshi K. p56(dok-2) as a cytokine-inducible inhibitor of cell proliferation and signal transduction. Embo J 2000;19:5114-5122.
4. Suzuki T. Coustan-Smith E, Mihara K. Campana D. Signals mediated by FcgammaRIIA suppress the growth of B-lineage acute lymphoblastic leukemia cells. Leukemia 2002;16:1276-1284.
5. Noguchi T, Matozaki T, Inagaki K, Tsuda M, Fukunaga K. Kitamura Y, Kitamura T, Shii K, Yamanashi Y, Kasuga M. Tyrosine phosphorylation of p62 (Dok) induced by cell adhesion and insulin: possible role in cell migration. Embo J 1999;18:1748-1760.
6. Martelli MP, Boomer J, Bu M, Bierer BE. T cell regulatin of p62 (dok) (Dok1) association with Crk-L. J Biol Chem 2001;276:45654-45661.
7. Di Cristofano A, Carpino N, Dunant N, Friedland G, Kobayashi R, Strife A, Wisniewski D, Clarkson B, Pandolfi PP, Resh MD. Molecular cloning and characterization of p56dok-2 defines a new familyi of RasGAP-binding proteins. J Biol Chem 1998; 273:4827-4830.
8. Safran M, Solomon I, Shmueli O. Lapidot M, Shen-Orr S, Adato A, Ben-Dor U, Esterman N, Rosen N, Peter I, Olender T, Chalifa-Caspi V, Lancet D. GeneCards 2002: towards a complete, object-oriented, human gene compendium. Bioinformatics 2002;18:1542-1543.
9. Carpino N, Wisniewski D, Strife A, Marshak D, Kobayashi R. Stillman B, Clarkson B. p62(dok): a constitutively tyrosin-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells. Cell 1997;88:197-204.
10. Kaplan DR, Morrison DK, Wong G, McCormick F, Williams LT. PDGF beta-receptor stimulates tyrosine phosphorylation of GAP and association of GAP with a signaling complex. Cell 1990;61:125-133.
11. Ellis C, Moran M, McCormick F, Pawson T. Phosphorylation of GAP and GAP-associated proteins by transforming and mitogenic tyrosine kinases. Nature 1990;343:377-381.
12. Kazlauskas A, Ellis C, Pawson T. Cooper JA. Binding of GAP to activated PDGF receptors. Science 1990;247:1578-1581.
13. Hosomi Y, Shii K, Ogawa W, Matsuba H, Yoshida M, Okada Y, Yokono K. Kasuga M, Baba S, Roth RA. Characterization of a 60-kilodalton substrate of the insulin receptor kinase. J Biol Chem 1994;269:11498-11502.
14. Wisniewski D, Strife A, Berman E, Clarkson B. c-kit ligand stimulates tyrosine phosphorylation of a similar pattern of phosphotyrosyl proteins in primary primitive normal hematopoietic progenitors that are constitutively phosphorylated in comparable primitive progenitors in chronic phase chronic myelogenous leukemia. Leukemia 1996;10:229-237.
15. Nelms K, Snow AL, Hu-Li J, Paul WE. A hematopoietic cell-specific rasGAP-interacting protein phosphorylated in response to cytokine stimulation. Immunity 1998;9:13-24.
16. Gold MR, Crowley MT, Martin GA. McCormick F, DeFranco AL. Targets of B lymphocyte antigen receptor signal transduction include the p21ras GTPase-activating protein (GAP) and two GAP-associated proteins. J Immunol 1993;150:377-386.
17. Vuica M, Desiderio S, Schneck JP. Diferential effects of B cell receptor and B cell receptor-FcgammaRIIB1 engagement on docking of Csk to GTPase-activating protein (GAP-associated p62. J Exp Med 1997;186:259-267.
18. Abramson J, Rozenblum G, Pecht I. Dok protein family members are involved in signaling mediated by the type 1 Fcepsilon receptor. Eur J Immunol 2003;33:85-91.
19. Ott VL, Tamir I, Niki M, Pandolfi PP, Cambier JC. Downstream of kinase, p62(dok), is a mediator of Fc gamma IIB inhibition of Fc epsilon RI signaling. J Immunol 2002;168:4430-4439.
20. Yang WC, Ghiotto M, Barbarat B, Olive D. The role of Tec protein-tyrosine kinase in T cell signaling. J Biol Chem 1999; 274:607-617.
21. Gerard A, Favre C. Garcon F, Nemorin JG, Duplay P, Pastor S. Collette Y, Olive D, Nunes JA. Functional interaction of RasGAP-binding proteins Dok-1 and Dok-2 with the Tec protein tyrosine kinase. Oncogene 2004;23:1594-1598.
22. Murakami H, Yamamura Y, Shimono Y, Kawai K, Kurokawa K, Takahashi M. Role of Dok1 in cell signaling mediated by RET tyrosine kinase. J Biol Chem 2002;277:32781-32790.
23. Shi N, Ye S, Bartlam M, Yang M, Wu J, Liu Y, Sun F, Han X, Peng X, Qiang B, Yuan J, Rao Z. Structural basis for the specific recognition of RET by the Dok1 phosphotyrosine binding domain. J Biol Chem 2004;279:4962-4969.
24. Yamakawa N, Tsuchida K, Sugino H. The rasGAP-binding protein, Dok-1, mediates activin signaling via serine/threonine kinase receptors. Embo J 2002;21:1684-1694.
25. Tang J, Feng GS, Li W. Induced direct binding of the adapter protein Nck to the GTPase-activiating protein-associated protein p62 by epidermal growth factor. Oncogene 1997;15:1823-1832.
26. Cong F, Yuan B, Goff SP. Characterization of a novel member of the DOK family that binds and modulates Abl signaling. Mol Cell Biol 1999;19:8314-8325.
27. DeClue JE, Vass WC, Johnson MR, Stacey DW, Lowy DR. Functional role of GTPase-activating protein in cell transformation by pp60v-src. Mol Cell Biol 1993;13:6799-6809.
28. Kashige N, Carpino N, Kobayashi R. Tyrosine phosphorylation of p62dok by p210bcr-abl inhibits RasGAP activity. Proc Natl Acad Sci USA 2000;97:2093-2098.
29. Di Cristofano A, Niki M, Zhao M, Karnell FG, Clarkson B, Pear WS, Van Aelst L, Pandolfi PP. A negative regulator of Ras and mitogen-activated protein kinase (MAPK) activity, opposes leukemogenesis by p210(bcr-abl). J Exp Med 2001;194:275-284.
30. Wick MJ, Dong LQ, Hu D, Langlais P, Liu F. Insulin receptor-mediated p62dok tyrosine phosphorylation at residues 362 and 398 plays distinct roles for binding GTPase-activating protein and Nek and is essential for inhibiting insulin-stimulated activation of Ras and Akt. J Biol Chem 2001;276:42843-42850.
31. Terpstra W, Prins A, Visser T, Wognum B, Wagemaker G, Lowenberg B, Wielenga J. Conditions for engraftment of human acute myeloid leukemia (AML) in SCID mice. Leukemia 1995;9:1573-1577.
32. Brennan JK, Lee KS, Abboud CN, Erickson-Miller CL, Keng PC. Interactions of dimethyl sulfoxide and granulocyte-macrophage colony-stimulating factors on the growth and maturation of HL-60 cells. J Cell Physiol 1987;132:246-254.
33. Collins SJ, Bodner A. Ting R, Gallo RC. Induction of morphological and functional differentiation of human promyelocytic leukemia cells (HL-60) by compounds which induce differentiation of murine leukemia cells. Int J Cancer 1980;25:213-218.
34. Breitman TR, Collins SJ, Keene BR. Terminal differentiation of human promyelocytic leukemic cells in primary culture in response to retinoic acid. Blood 1981;57:1000-1004.
35. Breitman TR, Selonick SE, Collins SJ. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci USA 1980;77:2936-2940.
36. Chaplinski TJ, Bennett TE, Caro JF. Alteration in insulin receptor expression accompanying differentiation of HL-60 leukemia cells. Cancer Res 1986;46:1203-1207.
37. Chaplinski TJ, Bennett TE. Induction of insulin receptor expression of human leukemic cells by 1 alpha, 25 dihydroxyvitamin D3. Leuk Res 1987;11:37-41.
38. Yen A, Sturgill R, Varvayanis S, Chern R. FMS (CSF-1 receptor) prolongs cell cycle and promotes retinoic acid-induced hypophosphorylation of retinoblasatoma protein, G1 arrest, and cell differentiation. Exp Cell Res 1996;229:111-125.
39. Yen A, Sturgill R, Varvayanis S. Increasing c-FMS (CSF-1 receptor) expression decreases retinoic acid concentration needed to cause cell differentiation and retinoblastoma protein hypophosphorylation. Cancer Res 1997;57:2020-2028.
40. Wightman J, Roberson MS, Lamkin TJ, Varvayanis S, Yen A. Retinoic acid-induced growth arrest and differentiation: retinoic acid up-regulates CD32 (Fc gammaRII) expression, the ectopic expression of which retards the cell cycle. Mol Cancer Ther 2002;1:493-506.
41. Battle TE. Levine RA, Yen A. Retinoic acid-induced blr1 expression promotes ERK2 activation and cell differentiation in HL-60 cells. Exp Cell Res 2000;254:287-298.
42. Stoeckler JD, Stoeckler HA, Kouttab N, Maizel AL. 1 alpha. 25-Dihydroxyvitamin D3 moedulates CD38 expression on human lymphocytes. J Immunol 1996;157:4908-4917.
43. Drach J, McQueen T, Engel H, Andreeff M, Robertson KA, Collins SJ, Malavasi F, Mehta K. Retinoic acid-induced expression of CD38 antigen in myeloid cells is mediated through retinoic acid receptor-alpha. Cancer Res 1994;54:746-1752.
44. Yen A, Roberson MS, Varvayanis S. Retinoic acid selectively activates the ERK2 but not JNK/SAPK or p38 MAP kinases when inducing myeloid differentiation. In Vitro Cell Dev Biol Anim 1999;35:527-532.
45. Yen A, Roberson MS, Varvayanis S, Lee AT. Retinoic acid induced mitogen-activated protein (MAP)/extracellular signal-regulated kinase (ERK) kinase-dependent MAP kinase activation needed to elicit HL-60 cell differentiation and growth arrest. Cancer Res 1998;58:3163-3172.
46. Gallea S, Lallemand F, Atfi A, Rawadi G, Ramez V, Spinella-Jaegle S, Kawai S, Faucheu C, Huet L, Baron R, Roman-Roman S. Activation of mitogen-activated protein kinase cascades is involved in regulation of bone morphogenetic protein-2-induced osteoblast differentiation in pluripotent C2C12 cells. Bone 2001;28:491-498.
47. Lai CF, Chaudhary L, Fausto A, Halstead LR, Ory DS, Avioli LV, Cheng SL. ERK is essential for growth, differentiation, integrin expression, and cell function in human osteoblastic cells. J Biol Chem 2001;276:14443-14450.
48. Woessmann W, Mivechi NF. Role of ERK activation in growth and erythroid differentiation of K562 cells. Exp Cell Res 2001; 264:193-200.
49. Palumbo A, Turco GL, Brossa C, D'Alberto M, Ghezzo F, Pegoraro L. Decrease of insulin binding to human acute leukemic cells during chemically induced differentiation. Boll Soc Ital Biol Sper 1980;56:1350-1354.
50. Lee AW, Nambirajan S, Moffat JG. CSF-1 activates MAPK-dependent and p53-independent pathways to induce growth arrest of hormone-dependent human breast cancer cells. Oncogene 1999;18:7477-7494.
51. Inoue S, Kontani K, Tsujimoto N, Kanda Y, Hosoda N, Hoshino S, Hazeki O, Katada T. Protein-tyrosine phosphorylation by IgG1 sublcass CD38 monoclonal antibodies is mediated through stimulation of the Fcgammall receptors in human myeloid cell lines. J Immunol 1997;159:5226-5232.
52. Werner T. Models for prediction and recognition of eukaryotic promoters. Mamm Genome 1999;10:168-175.
53. Werner T. Finding and decrypting of prometers contributes to the elucidation of gene function. In Silico Biol 2002;2:249-255.
54. Werner T. Promoters can contribute to the elucidation of protein function. Trends Biotechnol 2003;21:9-13.
55. Werner T. The state of the art of mammalian promoter recognition. Brief Bioinform 2003;4:22-30.
56. Overton JS, Overton GC. TESS: Transcription element search system, Technical Report CBIL-TR-1997-1001,v0.0. Computational Biology and Informatics, School of Medicine, University of Pennsylvania, 1997. URL: http://www.cbil. upenn.edu/tess.
57. Konopleva M, Estrov Z, Zhao S, Andreeff M, Mehta K. Ligation of cell surface CD38 protein with agonistic monoclonal antibody induces a cell growth signal in myeloid leukemia cells. J Immunol 1998;161:4702-4708.
58. Schwartz EL, Ishiguro K, Sartorelli AC. Induction of leukemia cell differentiation by chemotherapeutic agents. Adv Enzyme Regul 1983;21:3-20.
59. Munshi CB, Graeff R, Lee HC. Evidence for a causal role of CD38 expression in granulocytic differentiation of human HL-60 cells. J Biol Chem 2002;277:49453-49458.
60. Drach J, Zhao S, Malavasi F, Mehta K. Rapid induction of CD38 antigen on myeloid leukemia cells by all trans-retinoic acid. Biochem Biophys Res Commun 1993;195:545-550.
61. Kishimoto H, Hoshino S, Ohori M, Kontani K, Nishina H, Suzawa M, Kato S, Katada T. Molecular mechanism of human CD38 gene expression by retinoic acid. Identification of retinoic acid response element in the first intron. J Biol Chem 1998;273:15429-15434.
62. Battle TE, Roberson MS, Zhang T, Varvayanis S, Yen A. Retinoic acid-induced blrl expression requires RARalpha, RXR, and MAPK activation and uses ERK2 but not JNK/SAPK to accelerate cell differentiation. Eur J Cell Biol 2001; 80:59-67.
63. Hong HY, Varvayanis S, Yen A. Retinoic acid causes MEK-dependent RAF phosphorylation through RARalpha plus RXR activation in HL-60 cells. Differentiation 2001;68:55-66.
64. Berg KL, Siminovitch KA, Stanley ER. SHP-1 regulation of p62(DOK) tyrosine phosphorylation in macrophages. J Biol Chem 1999;274:35855-35865.
65. Niki M, Di Christofano A, Zhao M, Honda H, Hirai H, Van Aelst L, Cordon-Carlo C, Pandolfi PP. Role of Dok-1 and Dok-2 in leukemia suppression. J Exp Med 2004;200:1689-1695.
66. Yasuda T, Shirakata M, Iwama A, Asuka I. Ebihara Y, Osawa M, Honda K, Shinohara H, Sudo K, Tsuji K, Nakauchi H, Iwakura Y, Hirai H, Oda H, Yamamoto T, Yamanashi Y, Role of Dok-1 and Dok-2 in myeloid homeostasis and suppression of leukemia. J Exp Med 2004;200:1681-1687.